Gold prices hit fresh record highs ahead of Fed decision; copper retreats
EDINBURGH - Craneware plc (AIM:CRW.L), a healthcare financial performance solutions provider, announced Wednesday that shareholders approved all proposed capital reduction resolutions at its general meeting.
The meeting, held at Tanfield House in Edinburgh, saw shareholders vote overwhelmingly in favor of four special resolutions related to the company’s proposed capital restructuring. All resolutions received nearly 100% approval, with only minimal opposition.
The approved measures include capitalizing the company’s merger reserve, creating B ordinary shares with specific rights and restrictions, canceling those B shares once issued, and eliminating the share premium account. These actions will credit the resulting amounts to the company’s reserves.
The capital reduction remains subject to confirmation from the Court of Session in Edinburgh, with the first court hearing expected in late August 2025 and the second hearing anticipated in October 2025. The effective date of the capital reduction will be the business day following the court order confirming the reduction.
Approximately 69.22% of the company’s total voting rights participated in the meeting. As of August 18, 2025, Craneware had 35,409,802 ordinary shares in issue, excluding treasury shares.
Full details of the resolutions were provided to shareholders in a circular dated August 1, 2025, according to the company’s statement.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.